help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on December 30, 2005, doi:10.1165/rcmb.2005-0374OC

Am. J. Respir. Cell Mol. Biol., Volume 34, Number 4, April 2006, 473-480

A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0374OCv1
34/4/473    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goncharova, E. A
Right arrow Articles by Krymskaya, V. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goncharova, E. A
Right arrow Articles by Krymskaya, V. P

Submitted on October 5, 2005
Revised on December 29, 2005

Modulation of LAM Cell Migration and Invasiveness by Tumor Suppressor TSC2

Elena A Goncharova1*, Dmitriy A Goncharov1, Poay N Lim1, Daniel J Noonan2, and Vera P Krymskaya1

1 Department of Medicine, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, PA, USA, 2 Department of Biochemistry, University of Kentucky, Chandler Medical Center, Lexington, KY, USA

* To whom correspondence should be addressed. E-mail: goncharo{at}mail.med.upenn.edu.

The loss of TSC2 function is associated with the pathobiology of lymphangioleiomyomatosis (LAM), which is characterized by the abnormal proliferation, migration, and differentiation of smooth muscle-like cells within the lungs. While the etiology of LAM remains unknown, clinical and genetic evidence provides support for the neoplastic nature of LAM. The goal of this study was to determine the role of tumor suppressor TSC2 in the neoplastic potential of LAM cells. We show that primary cultures of human LAM cells exhibit increased migratory activity and invasiveness, which is abolished by TSC2 re-expression. We found that TSC2 also inhibits cell migration through its N-terminus, independent of its GTP-ase-activating protein (GAP) activity. LAM cells show increased stress fiber and focal adhesion formation, which is attenuated by TSC2 re-expression. The small GTPase RhoA is activated in LAM cells compared to normal human mesenchymal cells. Pharmacological inhibition of Rho activity abrogates LAM cell migration; RhoA activity was also abolished by TSC2 re-expression or TSC1 knock-down with specific siRNA. These data demonstrate that TSC2 controls cell migration through its N-terminus by associating with TSC1 and regulating RhoA activity, suggesting that TSC2 may play a critical role in modulating cell migration and invasiveness, which contributes to the pathobiology of LAM.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K. Inoki and K.-L. Guan
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment
Hum. Mol. Genet., April 15, 2009; 18(R1): R94 - R100.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
V. P. Krymskaya
Smooth Muscle like Cells in Pulmonary Lymphangioleiomyomatosis
Proceedings of the ATS, January 1, 2008; 5(1): 119 - 126.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H. Watz, K. Engels, S. Loeschke, M. Amthor, D. Kirsten, and H. Magnussen
Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets
Thorax, June 1, 2007; 62(6): 559 - 559.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Zarogiannis, C. Hatzoglou, P. A. Molyvdas, and K. Gourgoulianis
Lymphangioleiomyomatosis
Eur. Respir. J., December 1, 2006; 28(6): 1284 - 1284.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.
  Red In Translatin